CUPRINA HOLDINGS CAYMAN-A (CUPR) Stock Price, Forecast & Analysis
USA - NASDAQ:CUPR - KYG2592E1026 - Common Stock
CUPR Key Statistics, Chart & Performance
The current stock price of CUPR is 0.7343 USD. In the past month the price decreased by -22.44%.
CUPR Latest News, Press Relases and Analysis
CUPR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 17.94 | 14.34B | ||
| SOLV | SOLVENTUM CORP | 12.74 | 13.12B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.18 | 9.94B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 22.87 | 5.04B | ||
| LNTH | LANTHEUS HOLDINGS INC | 8.89 | 3.60B | ||
| HAE | HAEMONETICS CORP/MASS | 15.31 | 3.54B | ||
| ICUI | ICU MEDICAL INC | 17.15 | 3.37B | ||
| XRAY | DENTSPLY SIRONA INC | 6.66 | 2.10B | ||
| UFPT | UFP TECHNOLOGIES INC | 26.83 | 1.79B | ||
| NEOG | NEOGEN CORP | 21.3 | 1.39B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.30B | ||
| EMBC | EMBECTA CORP | 4.98 | 851.03M |
Related stock screener links
About CUPR
Company Profile
Cuprina Holdings (Cayman) Ltd. engages in the manufacturing, sale, and supply of medical devices to manage and accelerate healing and closure of chronic wounds. The company employs 14 full-time employees The company went IPO on 2025-04-10. Its segments include Maggot Debridement Therapy Product (MDT) and Cosmeceutical Product. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as MDT, which is an effective alternative to surgical debridement. The company has two lines of chronic wound care products in its pipeline, such as Collagen dressings, including sponges, particles and hydrogels utilizing bullfrog collagen derived from the valorization of abattoir waste streams of American bullfrogs (Lithobates catesbeianus) and products utilizing medical leeches for wound treatment.
Company Info
CUPRINA HOLDINGS CAYMAN-A
Block 1090, Lower Delta Road, #06-08
SG
Employees: 14
Phone: 6585127275
CUPRINA HOLDINGS CAYMAN-A / CUPR FAQ
What does CUPRINA HOLDINGS CAYMAN-A do?
Cuprina Holdings (Cayman) Ltd. engages in the manufacturing, sale, and supply of medical devices to manage and accelerate healing and closure of chronic wounds. The company employs 14 full-time employees The company went IPO on 2025-04-10. Its segments include Maggot Debridement Therapy Product (MDT) and Cosmeceutical Product. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as MDT, which is an effective alternative to surgical debridement. The company has two lines of chronic wound care products in its pipeline, such as Collagen dressings, including sponges, particles and hydrogels utilizing bullfrog collagen derived from the valorization of abattoir waste streams of American bullfrogs (Lithobates catesbeianus) and products utilizing medical leeches for wound treatment.
What is the current price of CUPR stock?
The current stock price of CUPR is 0.7343 USD. The price decreased by -3.58% in the last trading session.
What is the dividend status of CUPRINA HOLDINGS CAYMAN-A?
CUPR does not pay a dividend.
What is the ChartMill technical and fundamental rating of CUPR stock?
CUPR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the GICS sector and industry of CUPR stock?
CUPRINA HOLDINGS CAYMAN-A (CUPR) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the outstanding short interest for CUPRINA HOLDINGS CAYMAN-A?
The outstanding short interest for CUPRINA HOLDINGS CAYMAN-A (CUPR) is 2.07% of its float.
CUPR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CUPR.
CUPR Financial Highlights
Over the last trailing twelve months CUPR reported a non-GAAP Earnings per Share(EPS) of -0.09. The EPS decreased by -68.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -129.77% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |